When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Amarin (AMRN) has been re-defining the omega-3 market with last year's REDUCE-IT results, wherein they demonstrated that addition of Vascepa led to a 25% relative risk reduction in onset of first major cardiovascular event vs statin monotherapy. This was followed by a recent FDA label expansion for Vascepa, which significantly increased its addressable market. Meanwhile, Acasti (ACST) has been riding on the coattail of AMRN's results and has been witnessing significant share price appreciation over the past year.